✦ LIBER ✦

Pegaptanib for neovascular age-related macular degeneration

✍ Scribed by E.S.0. Gragoudas; A.P. Adamis; E.T. Cunningham Jr; M. Feinsod; D.R. Guyer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Year 2 Efficacy Results of 2 Randomized

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 537 KB

Pegaptanib sodium for the treatment of n

✍ Helen Kourlas; Daryl S. Schiller 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 825 KB

Pegaptanib sodium for occult choroidal n

✍ Atmani, K; Coscas, F; Coscas, G; Soubrane, G 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB

Pegaptanib Sodium for Neovascular Age-Re

✍ Donald J. D’Amico 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Cost-Effectiveness Model for Neovascular

✍ Jonathan C. Javitt; Gergana P. Zlateva; Stephanie R. Earnshaw; Andreas M. Pleil; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Pegaptanib sodium for age-related macula

✍ Sobha Sivaprasad 📂 Article 📅 2006 🏛 Wiley (John Wiley & Sons) ⚖ 118 KB